These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150 [TBL] [Abstract][Full Text] [Related]
7. DNA structural distortions induced by ruthenium-arene anticancer compounds. Gossens C; Tavernelli I; Rothlisberger U J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes. Bugarcic T; Nováková O; Halámiková A; Zerzánková L; Vrána O; Kaspárková J; Habtemariam A; Parsons S; Sadler PJ; Brabec V J Med Chem; 2008 Sep; 51(17):5310-9. PubMed ID: 18702458 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex. Wu K; Luo Q; Hu W; Li X; Wang F; Xiong S; Sadler PJ Metallomics; 2012 Feb; 4(2):139-48. PubMed ID: 22262368 [TBL] [Abstract][Full Text] [Related]
10. Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes. Liu HK; Wang F; Parkinson JA; Bella J; Sadler PJ Chemistry; 2006 Aug; 12(23):6151-65. PubMed ID: 16807967 [TBL] [Abstract][Full Text] [Related]
12. Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes. Hu W; Luo Q; Ma X; Wu K; Liu J; Chen Y; Xiong S; Wang J; Sadler PJ; Wang F Chemistry; 2009 Jul; 15(27):6586-94. PubMed ID: 19533706 [TBL] [Abstract][Full Text] [Related]
13. Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium. Marini V; Kasparkova J; Novakova O; Monsú Scolaro L; Romeo R; Brabec V J Biol Inorg Chem; 2002 Sep; 7(7-8):725-34. PubMed ID: 12203009 [TBL] [Abstract][Full Text] [Related]
14. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes. van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745 [TBL] [Abstract][Full Text] [Related]
15. Binding of organometallic ruthenium(II) anticancer compounds to nucleobases: a computational study. Gossens C; Tavernelli I; Rothlisberger U J Phys Chem A; 2009 Oct; 113(43):11888-97. PubMed ID: 19791792 [TBL] [Abstract][Full Text] [Related]
17. Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate. Wang F; Xu J; Habtemariam A; Bella J; Sadler PJ J Am Chem Soc; 2005 Dec; 127(50):17734-43. PubMed ID: 16351102 [TBL] [Abstract][Full Text] [Related]
18. Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis. Ang WH; Daldini E; Scolaro C; Scopelliti R; Juillerat-Jeannerat L; Dyson PJ Inorg Chem; 2006 Oct; 45(22):9006-13. PubMed ID: 17054361 [TBL] [Abstract][Full Text] [Related]
19. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Brabec V; Nováková O Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363 [TBL] [Abstract][Full Text] [Related]
20. Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts. Wang F; Chen H; Parsons S; Oswald ID; Davidson JE; Sadler PJ Chemistry; 2003 Dec; 9(23):5810-20. PubMed ID: 14673852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]